Reviewed by Hannah Dawes, Veterinary Behaviourist, Clinical Lead on 19 May 2026.
Your vet has just suggested that your pet might benefit from behavioural medication. Perhaps your dog can’t settle when you leave the house. Maybe your cat has started spraying despite a clean bill of health, or your parrot has been plucking its feathers for months. Whatever the reason, hearing the word “medication” can feel daunting. You might be wondering whether it’s really necessary or whether it’ll change who your pet is. You may even worry it means you’ve failed them.
You’re not alone in feeling this way. Questions about behavioural medication are some of the most common we hear from owners at Second Nature Behaviour. Unfortunately, there’s a great deal of misinformation out there that can make the decision feel even more overwhelming. Let’s look at five of the most persistent myths about behavioural medication for pets, and what the evidence actually says.
First, What Do We Mean by “Behavioural Medication”?
When we talk about behavioural medication, we mean psychoactive medications that a vet prescribes. They help manage conditions like anxiety, fear, phobias, compulsive behaviours, and excessive reactivity. Most are not sedatives or tranquillisers. They work on specific neurotransmitter systems in the brain to help regulate emotional states. The most common are serotonin, noradrenaline and gamma-aminobutyric acid (GABA).
There are several different classes of behavioural medication, and each works in a slightly different way depending on the condition. Some suit daily, long-term use to help regulate mood and reduce chronic anxiety. Others work on a short-term or situational basis, for example to help a pet cope with a specific stressful event. Vets have used many of these medications for decades in dogs, cats and even parrots. In dogs there is a substantial evidence base for their safety and effectiveness; in cats and parrots the research is smaller but growing.
Importantly, a vet always prescribes and monitors behavioural medication. At Second Nature Behaviour, we work on veterinary referral, which means your vet is always involved in your pet’s care, including any decisions about medication. Our Veterinary Behaviourists are available to advise your pet’s primary care vet on medications as needed.
Myth 1: “Medication Will Change My Pet’s Personality”
This is perhaps the most common worry owners have, and it’s completely understandable. Your pet’s quirky habits, playful energy, and unique character are part of what makes them who they are. The last thing you want is to lose that.
The good news is that this isn’t what behavioural medication sets out to do. The goal of psychoactive medication isn’t to change your pet’s personality. It’s to address the underlying emotional states, like chronic anxiety or fear, that are preventing your pet from being themselves. Think of it this way. If your dog is too anxious to enjoy a walk, or your cat is too stressed to play, the anxiety is masking their true personality. Medication aims to lift that cloud, not create a new one.
Research suggests that appropriately prescribed behavioural medication, combined with a behaviour plan, targets problematic emotional states like fear, anxiety, and excessive reactivity rather than simply suppressing behaviour. The aim is to ease those states without changing the core characteristics that make your pet who they are. If you do notice any unexpected changes, such as your pet seeming less interested in their favourite activities, your vet can adjust the dose or try a different medication entirely. The effects are not permanent, and your vet will work with you to find the right fit.
Myth 2: “It’s Just a Sedative — My Pet Will Be a Zombie”
This is one of the more persistent myths, and it has a grain of historical truth behind it. Some older behavioural medications caused noticeable sedation and lethargy. It’s not surprising that this reputation stuck.
However, vets now favour medications that don’t cause significant sedation at therapeutic doses, and where a short-acting event medication is used the aim is a calming, not a sedating, dose. Daily behavioural medications work by gradually adjusting neurotransmitter levels in the brain over several weeks; situational medications act much faster. They don’t knock your pet out — they help regulate the neurochemical imbalances that drive anxiety and fear responses. Your pet should still want to play, eat, go for walks, and engage with you just as they always have.
If your pet does seem overly sedated on a particular medication, that’s a signal to talk to your vet. It’s not a sign that sedation is the intended effect. Sedation is explicitly not the goal of modern behavioural medication. The aim is for your pet to feel calmer and more able to cope, not drowsy and disconnected.
This applies across species, too. For cats, vets choose behavioural medications that reduce anxiety and reactivity without heavy sedation. For parrots experiencing conditions like feather-damaging behaviour, vets may use psychoactive medication alongside environmental enrichment to ease the emotional distress driving the behaviour. Again, the aim is not to sedate the bird.
Myth 3: “My Pet Will Be on Medication Forever”
The idea of a pet being on behavioural medication indefinitely can feel overwhelming. But in many cases, pets don’t need behavioural medication permanently – although some conditions, such as urine marking in cats, often return if medication is stopped.
How long your pet needs medication depends entirely on the individual animal and their specific situation. Some pets benefit from a course of medication lasting several months. During this time, they also work through a behaviour modification plan (BMP) with a qualified behaviourist. The medication helps create a window where the pet is calm enough to actually learn new responses and coping strategies. Once things have been going well for a while, your vet may try gradually reducing the dose.
For other animals, particularly those with deep-rooted anxiety or neurochemical imbalances, longer-term medication may be the kindest and most effective option. That’s absolutely fine. Just as some people benefit from long-term medication for anxiety or depression, some pets thrive with ongoing pharmacological support. This isn’t a failure; it’s appropriate medical care.
The key point is that you and your vet make the decision together. It’s always individual, and always based on what gives your pet the best quality of life.
Myth 4: “If My Pet Needs Medication, It Means I’ve Failed”
This is the myth that tends to cause the most guilt, and it couldn’t be further from the truth.
Behavioural problems in animals are rarely about what the owner has or hasn’t done. Anxiety, fear, and compulsive behaviours have complex origins involving genetics, early life experiences, neurochemistry, and environment. Research in dogs shows that fearfulness has a substantial heritable component. In many cases, your pet was predisposed to these challenges long before they came into your life.
Choosing to explore behavioural medication for your pet isn’t a sign of failure. It’s a sign that you’re taking their emotional welfare seriously and that you’re willing to consider every tool available to help them. For some animals, particularly those experiencing severe fear or panic, medication can provide relief from genuine mental suffering. Withholding medication from an animal in distress because of stigma around its use would be the less compassionate choice.
It’s also worth remembering that medication is almost never the only intervention. It works best as part of a comprehensive approach that includes behaviour modification, environmental management, and ongoing support from both your vet and a qualified clinical animal behaviourist.
Behavioural Medication Is Not a Magic Cure — And That’s a Good Thing
Now we’ve addressed the myths, it’s important to be honest about what behavioural medication can’t do.
Medication alone will not “fix” a behaviour problem. It cannot teach your dog to feel safe when left alone. Nor can it teach your cat to tolerate a new housemate. And it cannot teach your parrot to stop plucking its feathers. What it can do is ease the underlying anxiety, fear and overwhelming arousal. Those emotions make it so difficult for your pet to learn new ways of coping.
Think of behavioural medication as creating the conditions for learning. When an animal is chronically anxious or emotionally overloaded, stress hormones like cortisol and adrenaline flood its body. In that state, the brain struggles to take in new learning. Medication helps bring those stress levels down. Then behaviour modification techniques — like desensitisation, counterconditioning, and enrichment — can actually take effect.
This is why medication is most effective when combined with a structured behaviour modification plan, developed by a qualified professional. When an animal is on medication, our tailored plans make the most of the calmer state it brings. The medication opens the door; the behaviour work helps your pet walk through it.
How Behavioural Medication for Pets Works Across Species
Dogs
Dogs are the species with the most licensed behavioural medications. There is well-established evidence for conditions including separation anxiety, noise phobias, generalised anxiety, and fear-based aggression. Several behavioural medications hold licences for specific conditions in dogs, giving vets a strong evidence base. For other species and conditions, vets can prescribe under the prescribing cascade.
Cats
For cats, vets increasingly see behavioural medication as a valuable tool. It can help particularly with conditions like inter-cat aggression, urine marking, generalised anxiety, and self-directed behaviours. Medication cannot teach a cat how to behave, and on its own it rarely resolves a problem behaviour. But it can reduce the arousal, excitability, and anxiety that drive those behaviours, making environmental and behavioural interventions far more effective.

Parrots
Parrots present a unique challenge. Feather-damaging behaviour, one of the most common behavioural problems in captive psittacines, can have both medical and psychological components. Environmental enrichment, particularly more foraging opportunities, is the foundation of treatment. However, some birds with deep-rooted behavioural distress may benefit from psychoactive medication alongside environmental and behavioural changes. The evidence base for avian psychopharmacology is smaller than for dogs and cats. Even so, vets have used several medications in parrots, and a small placebo-controlled trial in cockatoos found a significant improvement in feather picking.

When Should You Consider Behavioural Medication for Your Pet?
Behavioural medication isn’t right for every pet or every situation. Your vet is most likely to recommend it when:
- Your pet is experiencing significant distress that affects their quality of life, such as severe separation anxiety, noise phobias, or persistent fear.
- The behaviour problem has an underlying emotional component (anxiety, fear, panic) that makes it difficult for your pet to respond to behaviour modification alone.
- Your pet has reached a plateau in their behaviour modification programme and isn’t making further progress despite consistent effort.
- The situation is urgent – for example, your pet risks injuring themselves or others through panic or fear.
If your vet or clinical animal behaviourist has suggested medication, it’s because they believe it could genuinely improve your pet’s wellbeing. It’s always worth having an open conversation with them about your concerns. A good professional will explain why they recommend it, what to expect, and how it fits the wider plan.
The Bottom Line
Behavioural medication for pets is not a magic cure, and it’s not something to fear. It’s a well-researched, carefully managed tool. Used alongside behaviour modification, it can make a genuine difference to your pet’s emotional welfare and quality of life.
If you’re concerned about your pet’s behaviour, get in touch with us at Second Nature Behaviour. We work alongside your vet on evidence-based plans that look at the whole picture, including whether medication might help.
References
- Boehringer Ingelheim Vetmedica GmbH. (2026). Pexion 400 mg tablets for dogs: Summary of product characteristics (Vm 61700/5064; amended April 2026). Veterinary Medicines Directorate Product Information Database. https://www.vmd.defra.gov.uk/productinformationdatabase/files/SPC_Documents/SPC_3030270.PDF
- Denenberg, S., & Dubé, M. B. (2018). Tools for managing feline problem behaviours: Psychoactive medications. Journal of Feline Medicine and Surgery, 20(11), 1034–1045. https://doi.org/10.1177/1098612X18806760
- Engel, O., Müller, H. W., Klee, R., Francke, B., & Mills, D. S. (2019). Effectiveness of imepitoin for the control of anxiety and fear associated with noise phobia in dogs. Journal of Veterinary Internal Medicine, 33(6), 2675–2684. https://doi.org/10.1111/jvim.15608
- Forte Healthcare Ltd. (2026). Reconcile 64 mg chewable tablets for dogs: Summary of product characteristics (Vm 27819/5005; revised March 2026). Veterinary Medicines Directorate Product Information Database. https://www.vmd.defra.gov.uk/productInformationdatabase/files/SPC_Documents/SPC_3101234.PDF
- Handegård, K. W., Storengen, L. M., Joergensen, D., & Lingaas, F. (2023). Genomic analysis of firework fear and noise reactivity in standard poodles. Canine Medicine and Genetics, 10, Article 2. https://doi.org/10.1186/s40575-023-00125-0
- Hart, B. L., Cliff, K. D., Tynes, V. V., & Bergman, L. (2005). Control of urine marking by use of long-term treatment with fluoxetine or clomipramine in cats. Journal of the American Veterinary Medical Association, 226(3), 378–382. https://doi.org/10.2460/javma.2005.226.378
- Ilska, J., Haskell, M. J., Blott, S. C., Sánchez-Molano, E., Polgar, Z., Lofgren, S. E., Clements, D. N., & Wiener, P. (2017). Genetic characterization of dog personality traits. Genetics, 206(2), 1101–1111. https://doi.org/10.1534/genetics.116.192674
- Karagiannis, C. I., Burman, O. H. P., & Mills, D. S. (2015). Dogs with separation-related problems show a “less pessimistic” cognitive bias during treatment with fluoxetine (Reconcile™) and a behaviour modification plan. BMC Veterinary Research, 11, Article 80. https://doi.org/10.1186/s12917-015-0373-1
- King, J. N., Simpson, B. S., Overall, K. L., Appleby, D., Pageat, P., Ross, C., Chaurand, J. P., Heath, S., Beata, C., Weiss, A. B., Muller, G., Paris, T., Bataille, B. G., Parker, J., Petit, S., & Wren, J. (2000). Treatment of separation anxiety in dogs with clomipramine: Results from a prospective, randomized, double-blind, placebo-controlled, parallel-group, multicenter clinical trial. Applied Animal Behaviour Science, 67(4), 255–275. https://doi.org/10.1016/S0168-1591(99)00127-6
- Korpivaara, M., Laapas, K., Huhtinen, M., Schöning, B., & Overall, K. (2017). Dexmedetomidine oromucosal gel for noise-associated acute anxiety and fear in dogs—a randomised, double-blind, placebo-controlled clinical study. Veterinary Record, 180(14), 356. https://doi.org/10.1136/vr.104045
- Lumeij, J. T., & Hommers, C. J. (2008). Foraging ‘enrichment’ as treatment for pterotillomania. Applied Animal Behaviour Science, 111(1–2), 85–94. https://doi.org/10.1016/j.applanim.2007.05.015
- Meehan, C. L., Millam, J. R., & Mench, J. A. (2003). Foraging opportunity and increased physical complexity both prevent and reduce psychogenic feather picking by young Amazon parrots. Applied Animal Behaviour Science, 80(1), 71–85. https://doi.org/10.1016/S0168-1591(02)00192-2
- Mills, D., Karagiannis, C., & Zulch, H. (2014). Stress—its effects on health and behavior: A guide for practitioners. Veterinary Clinics of North America: Small Animal Practice, 44(3), 525–541. https://doi.org/10.1016/j.cvsm.2014.01.005
- Orion Corporation. (2026). Sileo 0.1 mg/ml oromucosal gel for dogs: Summary of product characteristics (Vm 06043/5002; approved 30 March 2026). Veterinary Medicines Directorate Product Information Database. https://www.vmd.defra.gov.uk/productinformationdatabase/files/SPC_Documents/SPC_3219375.PDF
- Royal College of Veterinary Surgeons. (n.d.). Veterinary medicines (Supporting guidance to the Code, Chapter 4). Retrieved November 3, 2026, from https://www.rcvs.org.uk/setting-standards/advice-and-guidance/code-of-professional-conduct-for-veterinary-surgeons/supporting-guidance/veterinary-medicines/
- Seibert, L. M. (2007). Pharmacotherapy for behavioral disorders in pet birds. Journal of Exotic Pet Medicine, 16(1), 30–37. https://doi.org/10.1053/j.jepm.2006.11.007
- Seibert, L. M., Crowell-Davis, S. L., Wilson, G. H., & Ritchie, B. W. (2004). Placebo-controlled clomipramine trial for the treatment of feather picking disorder in cockatoos. Journal of the American Animal Hospital Association, 40(4), 261–269. https://doi.org/10.5326/0400261
- Simpson, B. S., Landsberg, G. M., Reisner, I. R., Ciribassi, J. J., Horwitz, D., Houpt, K. A., Kroll, T. L., Luescher, A., Moffat, K. S., Douglass, G., Robertson-Plouch, C., Veenhuizen, M. F., Zimmerman, A., & Clark, T. P. (2007). Effects of Reconcile (fluoxetine) chewable tablets plus behavior management for canine separation anxiety. Veterinary Therapeutics, 8(1), 18–31.
- van Zeeland, Y. R. A., Spruit, B. M., Rodenburg, T. B., Riedstra, B., van Hierden, Y. M., Buitenhuis, B., Korte, S. M., & Lumeij, J. T. (2009). Feather damaging behaviour in parrots: A review with consideration of comparative aspects. Applied Animal Behaviour Science, 121(2), 75–95. https://doi.org/10.1016/j.applanim.2009.09.006
- Veterinary Medicines Directorate. (n.d.). Product information database: Clomicalm 20 mg tablets for dogs (Product A010900). Retrieved November 3, 2026, from https://www.vmd.defra.gov.uk/productInformationdatabase/product/A010900
- Veterinary Medicines Directorate. (2026, May 19). The cascade: Prescribing unauthorised medicines. GOV.UK. https://www.gov.uk/guidance/the-cascade-prescribing-unauthorised-medicines
- Veterinary Medicines Regulations 2013, SI 2013/2033, Sch. 3, para. 4. https://www.legislation.gov.uk/uksi/2013/2033/schedule/3
- Virbac. (2026). Clomicalm 5 mg, 20 mg and 80 mg tablets for dogs: Summary of product characteristics (Vm 05653/5027–5029; approved 22 February 2026). Veterinary Medicines Directorate Product Information Database. https://www.vmd.defra.gov.uk/ProductInformationDatabase/files/SPC_Documents/SPC_2937814.PDF
